Hi 89,
Thats why I posted that .
Will be hard in my opinion for the FDA not to issue a EUA for MSB.
As for NVS not going ahead I think thats just stupid talk.
This deal with NVS is as important to them as MSB.
It breaks them away from their main competitors.
And they are a global company.
Might get news today but at any rate the share price is at give away prices at the moment.
Aloha.
Cell Therapy News/Articles, page-9758
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.105(7.64%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.49 | $1.38 | $8.181M | 5.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25443 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 60811 | 4 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |